| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 22, 2019 | 30.00 | 0.00 | 0.00 | 29.70 | 0 |
| Apr 19, 2019 | 30.00 | 30.00 | 29.20 | 29.70 | 29,700 |
| Apr 18, 2019 | 30.00 | 30.00 | 29.20 | 29.70 | 29,700 |
| Apr 17, 2019 | 29.10 | 31.00 | 26.50 | 29.70 | 382,475 |
| Apr 16, 2019 | 29.00 | 30.00 | 29.00 | 29.80 | 42,358 |
| Name | Circassia Pharmaceuticals | Epic | CIR |
|---|---|---|---|
| ISIN | GB00BJVD3B28 | Currency | GBX |
| Type | Equity | Trading Segment | AMSM |
| Record Status | Active | Trading Status | Opening Auction Call |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 10,000 | Prev Close | 29.70 |
| Shares in Issue (m) | 374.87 | Market Cap (£m) | 111.34 |
| PE Ratio | -0.96 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -31.00 | EPS Growth (%) | 35.42 |
| PEG | -0.03 | DPS Growth (%) | n/a |
| ROCE | -30.57 | Net Gearing | 33.08 |
| Quick Ratio | 2.76 | Current Ratio | 2.92 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 23 Apr | Peel Hunt | Buy | 29.55 | 90.00 | - | Reiterates |
| 01 Apr | Peel Hunt | Buy | 29.55 | 90.00 | - | Reiterates |
| 12 Mar | Peel Hunt | Buy | 29.55 | - | 90.00 | Resumes |
| 01 Feb | Peel Hunt | Under Review | 29.55 | - | - | Under Review |
| 24 Jan | RBC Capital Markets | Sector Performer | 29.55 | 81.00 | 65.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 17 Jul 2017 | Steven Harris | Exercise | 535,375 @ 0.08p | £428.30 |
| 18 Sep 2015 | Charles Swingland | Sell | 1,230,000 @ 318.24p | £3,914,352.00 |
| 18 Sep 2015 | Charles Swingland | Sell | 9,000 @ 318.72p | £28,684.80 |
| 18 Sep 2015 | Charles Swingland | Sell | 754,548 @ 320.24p | £2,416,364.52 |
| 27 Mar 2014 | Dr Rod Hafner | Exercise | 212,375 @ 0.08p | £169.90 |
